Latest filing published 21 Nov 2022 for Wejo Group Ltd.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -6.9%Entry US$8.30 · Close at T+365 US$7.73
- -21.9%Entry US$9.31 · Close at T+365 US$7.27
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
John T. Maxwell: trading record in brief
This profile gathers the share dealings of John T. Maxwell across 2 companies, led by Aquestive Therapeutics, Inc. and Wejo Group Ltd. We count 6 filings; the first trade dates from 21 November 2018 and the latest from 19 November 2022.
Both buying and selling appear: 2 purchases worth €125k, against 1 sale worth €20k. Purchases outweigh sales by €105k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 3 share grants.
On 21 November 2022 came the latest disclosure, a share grant in Wejo Group Ltd. The last purchase on record was published on 7 December 2018, which is 2,893 days ago. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to John T. Maxwell
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 74,456 shares@ €0.810755.2% of flowCommon SharesSEC:0001864448-22-000101:0
- 36,757 shares@ US$1.36100.0% of flowCommon SharesSEC:0001864448-22-000066:1
- 36,757 shares@ €1.332444.8% of flowCommon SharesSEC:0001864448-22-000066:0
- 3,000 shares@ US$8.00100.0% of flowCommon StockSEC:0001214659-20-007366:0
- 5,000 shares@ US$8.8726.9% of flowCommon StockSEC:0001140361-18-044723:0Canonical exit: 6 Mar 2019 (T+90)
- 10,000 shares@ US$9.8059.3% of flowCommon StockSEC:0001140361-18-043653:0Canonical exit: 19 Feb 2019 (T+90)
6 of 6 declarations